SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as investors digest a strong earnings beat and positive forward guidance, fueling an intense debate over whether the company's aggressive foundry capital expenditures signal long-term growth or unsustainable cash burn. The community remains deeply divided, with bulls pointing to record revenue growth as a sign of a successful turnaround, while bears cite the potential for dilution and market manipulation as reasons to expect a volatile sell-off.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing significant downward pressure following an earnings report that left investors concerned about heavy AI and robotics spending amidst a lack of clear timelines for project profitability. While community discussions remain deeply polarized between those betting on a rapid V-shaped recovery and others warning of a long-term correction toward lower valuation levels, market participants are actively debating the impact of aggressive institutional selling and potential hedging flows on near-term price volatility.

ChronoScale Holdings Corp. engages in the development and operation of GPU-accelerated cloud infrastructure designed to support the demanding computational requirements of modern AI applications. The company was founded on June 18, 2026 and is headquartered in Dallas, TX.

ChronoScale Holdings Corp.

ChronoScale Corp.

ChronoScale Corp. is gaining significant attention from the community as investors speculate on an imminent short squeeze driven by its extremely low float and heavy institutional ownership. Traders are actively debating whether the stock's recent volatility is a setup for a parabolic move fueled by potential AI partnerships or if the rapid price swings point to a high-risk scenario.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart Holdings is trending as investors weigh recent funding deals and pending bank charter approvals against the stock's significant short interest and volatile price performance. The community is sharply divided, with some betting on a major short squeeze and long-term AI-lending growth, while others express deep frustration over the stock's persistent underperformance relative to broader fintech and sector peers.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. (HIMS) is experiencing significant market interest following a positive FDA advisory panel vote recommending the inclusion of several peptides on the 503A compounding list. The community is actively debating the potential for a short squeeze given the stock's high short interest and remains focused on upcoming revenue catalysts as investors weigh the regulatory developments against broader growth sector trends.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

Raytheon Technologies is trending as investors react to a powerful beat-and-raise earnings report, with community members highlighting the company's record $289 billion backlog and sustained demand for military and aerospace technologies. Traders are actively debating the potential for long-term growth driven by global security needs and the ongoing replenishment of critical defense stockpiles.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is rallying as investors digest a massive 20-year lease agreement worth at least $6.6 billion, with community sentiment shifting as the company pivots from a pure-play bitcoin miner to an AI infrastructure and data center provider. The community is heavily focused on the stock's significant short interest and the potential for a major re-rating, particularly as the deal includes exclusive rights to expand the company's Texas portfolio, which many view as a critical move in the high-demand compute market.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Firefly Aerospace is currently a focal point for investors weighing its long-term potential in defense and space infrastructure against recent price volatility and sector-wide selling pressure. Community discussion is heavily centered on the stock's discounted valuation following a sharp correction, while many participants closely track its mission execution and competitive positioning against larger industry peers like SpaceX.

Conagra Brands, Inc. engages in the manufacture and sale of processed and packaged foods. It operates through the following segments: Grocery and Snacks, Refrigerated and Frozen, International, and Foodservice. The Grocery and Snacks segment includes branded, and shelf stable food products sold in various retail channels in the United States. The Refrigerated and Frozen segment is composed of branded, and temperature-controlled food products sold in various retail channels in the United States. The International segment offers branded food products in various temperature states, sold in various retail and foodservice channels outside of the United States. The Foodservice segment focuses on branded and customized food products, including meals, entrees, sauces, and a variety of custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The company was founded by Alva Kinney and Frank Little in 1919 and is headquartered in Chicago, IL.

Conagra Brands Inc

Conagra Brands is drawing significant investor attention due to its persistent downtrend and new 52-week lows, with the community actively debating whether the stock represents a deep-value opportunity or a dividend trap ahead of upcoming management changes. Discussions center on the sustainability of its high dividend yield, potential for M&A activity, and skepticism regarding the impact of weight-loss drugs on the processed food sector.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors weigh significant upside potential from its growing product portfolio against ongoing uncertainty regarding Medicare reimbursement for its kidney drug, Xphozah. The community is actively debating the stock's valuation, questioning management's communication, and anticipating catalysts from upcoming quarterly results and potential regulatory updates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ADIL Stock Eyes Best Day In Over 5 Years — Major Pipeline Overhaul And $64M Raise Fuel Rally

Equity

Adial on Thursday announced that it has bought privately held Azora Therapeutics.

Adial Pharmaceuticals Applies For FDA Priority Voucher Program For AD04

(RTTNews) - Adial Pharmaceuticals, Inc. (ADIL) on Monday said it has submitted its AD04 application for consideration under the U.S. Food and Drug Administration Commissioner's National Priority Voucher Pilot Program (CNPV...

Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder

Adial backs H.R. 7091 targeting AUD in veterans, spotlighting harm reduction therapies and expanding research beyond abstinence-based care.read more...

Why Did Adial Pharmaceuticals Stock Plunge Over 20% After Hours Today?

The reverse split is intended to bring the company back into compliance with Nasdaq’s $1 minimum bid price rule.

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.

All You Need to Know About Adial Pharmaceuticals (ADIL) Rating Upgrade to Buy

Adial Pharmaceuticals (ADIL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why

Adial Pharmaceuticals (ADIL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Retail Traders Flock To Adial Pharma After Patent News Sends Shares Soaring

Adial Pharmaceuticals jumped to its highest level since February after receiving a U.S. patent for its precision medicine approach to treating addiction. The patent supports the use of AD04 in patients with specific genetic markers.

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Adial Pharmaceuticals Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.68
Prev Close	$2.70
Open	$2.66
Dividend Yield	0.00%
50-Day Moving Average	$2.46
Beta	0.88
Avg. Volume	1.11M
PE Ratio	-0.27

52-Week High	$18.90
52-Week Low	$1.31
Market Capitalization	$5.91M
EPS (Annual)	-$11.93
Price to Book	1.09
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

ADILAdial Pharmaceuticals Inc

Latest ADIL News